As SMA is caused by mutations resulting in decreased SMN protein levels, we hypothesized that the paralysis phenotype observed in smn-1(gk) mutants was due to an insufficient level of wild-type SMN-1 protein. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.